This document provides an introduction to health economics. It discusses how health care expenditures have increased dramatically, prompting concerns about scarce resources. Health economic evaluation is presented as a tool to demonstrate the value of health care interventions in terms of both clinical and economic outcomes. The key concepts of health economics evaluation are defined, including comparing costs and outcomes of at least two alternatives from various perspectives. Types of economic analyses - cost analysis, cost-effectiveness analysis, cost-utility analysis - are introduced. The document provides examples of health economic evaluations influencing coverage decisions for treatments in Thailand.
> Is health tradable?
> Which lottery?
> Positive time preference
> Discounting
> Why do we discount?
> How to discount?
> Impact of discounting
> Discounting in HEE - uniform discounting and differential discounting
> Choosing a discount rate
> Guidelines on discounting
> Discounting future values
> Take home message
> Is health tradable?
> Which lottery?
> Positive time preference
> Discounting
> Why do we discount?
> How to discount?
> Impact of discounting
> Discounting in HEE - uniform discounting and differential discounting
> Choosing a discount rate
> Guidelines on discounting
> Discounting future values
> Take home message
Here is the slide on Healthcare economic evaluation. The content of this presentation doesn't belong to me. They are copied from several literature and internet
Supply of health and medical care
Definition and Law of Supply.
The health care production function.
Cost production in health care.
Factors determine price and quantity of health care.
Factors affecting Supply.
Investment on healthcare.
Health insurance and supply in healthcare.
Market Equilibrium.
References
Questions
This presentation gives a basic introduction to the field of health economics and includes important concepts like that of efficiency, equity, opportunity costs, demand and supply and also includes financial evaluation
Health Economics is the science of assessing cost and benefits of health care therapies and service. HE is about making choices between options, when there is scarcity of resources.
Introduction
What is definition and law of supply
Factors determine supply for health care services
Factors determine price & quantity of health care
What is the production function for health
Market equilibrium
Investing in the healthcare sector
Cost production in healthcare
Different healthcare system
Models of non-profit agencies
References
discussion on Health Economics and Health Care in our country and abroad, and what resources are given by the private sectors and with the very scarce help from the DOH, national and local government, and from the support given by WHO.
Concept of Economic Evaluation in Health CarePrabesh Ghimire
Declaration: The materials incorporated in this document have come from variety of sources and compiler bears no responsibilities for any information contained herein. The compiler acknowledges all the sources although references have not been explicitly cited for all the contents in this document.
students wonder exactly what health economics is. is it about money in health, more health for the same money ? about health in hospitals or health of the country.
Here is the slide on Healthcare economic evaluation. The content of this presentation doesn't belong to me. They are copied from several literature and internet
Supply of health and medical care
Definition and Law of Supply.
The health care production function.
Cost production in health care.
Factors determine price and quantity of health care.
Factors affecting Supply.
Investment on healthcare.
Health insurance and supply in healthcare.
Market Equilibrium.
References
Questions
This presentation gives a basic introduction to the field of health economics and includes important concepts like that of efficiency, equity, opportunity costs, demand and supply and also includes financial evaluation
Health Economics is the science of assessing cost and benefits of health care therapies and service. HE is about making choices between options, when there is scarcity of resources.
Introduction
What is definition and law of supply
Factors determine supply for health care services
Factors determine price & quantity of health care
What is the production function for health
Market equilibrium
Investing in the healthcare sector
Cost production in healthcare
Different healthcare system
Models of non-profit agencies
References
discussion on Health Economics and Health Care in our country and abroad, and what resources are given by the private sectors and with the very scarce help from the DOH, national and local government, and from the support given by WHO.
Concept of Economic Evaluation in Health CarePrabesh Ghimire
Declaration: The materials incorporated in this document have come from variety of sources and compiler bears no responsibilities for any information contained herein. The compiler acknowledges all the sources although references have not been explicitly cited for all the contents in this document.
students wonder exactly what health economics is. is it about money in health, more health for the same money ? about health in hospitals or health of the country.
Health Economics with Taxation and Land Reform Midterm.ppt
Discusses:
The Demand for Health Care
: Introduction
: Determinants of Health Seeking Behavior
The Supply of Health Care Services
: Factors that affect the Supply of Manpower
: The Supply of Hospital Services
The Concept of Demographic Transition
Lung cancer, which accounted for 1.8 million cases in 2012, is a serious issue in Asia. While it is primarily driven by smoking, non-smoking lung cancer is also growing due to pollution and oncogenic mutation.
Find out more about the severity of lung cancer in China, Taiwan, India, and Korea in our latest Social Innovation Playbook Series on SlideShare
Health Economics and Health Finance :Jordan Health Policy Directions Musa Ajlouni
This presentation includes general introduction to health economics,the concept of market failure in health, health financing including health insurance and major challenges related to healthcare financing in Jordan and some policy directions to face these challenges.
Presentation by David Wonderling, Head of Health Economics at National Guideline Centre, Royal College of Physicians and Lauren Ramjee, Senior Health Economist, Royal College of Physicians.
This workshop outlines the principles of health economic evaluation for the NHS.
CUA is a formal economic technique for assessing the efficien
cy of healthcare interventions. It is
considered by some to be a specific type of cost effectiveness analysis in which the measure of
effectiveness is a utility or preference adjusted outcome.
Productivity in the health sector -- Peter Smith, United KingdomOECD Governance
This presentation was made by Peter Smith, United Kingdom, at the 6th Meeting of the Joint OECD DELSA-GOV Network on Fiscal Sustainability of Health Systems, held at the OECD Conference Centre, Paris, on 18-19 September 2017
Nik Nuradlina N.A,Mohd Syamir M. S. ,Noor Nashreen M.S.,Rozita M.
Pharmacy Department, National Cancer Institute, Putrajaya.
1st Clinical Audit Pharmacy Department
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
1. Introduction of Health Economics
Nathorn Chaiyakunapruk
Professor of Health Economics
School of Pharmacy
Monash University Malaysia
2. Introduction
• Health care expenditures increased dramatically
• Clinicians and policy makers are concerned
• Why?: Scarce resources
• Decisions are mostly based on
– evidence-based medicine (safety, efficacy, quality)
– the cost of drugs (per course), and its budget impact
• The true value of a drug is mostly not assessed
3. “Value” of Health Care
• Definition of “value” in health care: the health outcomes
achieved per dollar spent (ME Porter 2006)
– Values should therefore be defined around the patients rather
than the service providers
– Values depends on results, NOT inputs
– Values demonstration will benefit all players in the system
• Longitudinal assessment on costs and outcomes
required
• Health economic evaluation can be used as a tool to
demonstrate value of health care interventions
3
4. Terminology
• Health economics
Application of economics in health care
• Health economics evaluation / economic evaluation
Evaluation of economics and outcomes of healthcare
intervention or program
• Pharmacoeconomics
Health economic evaluation related to pharmacy/
pharmaceuticals. It has been used in a broader context
then “pharmaceuticals”
5. Pharmacoeconomics
5
Pharmacoeconomics vs
Health economics
Health
Economics
Health
Economic
Evaluation
Health economics:
Health care financing system, Optimization of health
care system, Understanding demand and supply of
health care,….
6. Fundamentals of Health Economics (HE)
• Under limited resources, everyone including policy decision
makers and clinicians have to make choices
• HE answers the question when comparing 2 choices:
– Whether the benefits incurred from new technolgoy (compared to usual
care) is worth the additional “total” expenses incurred?
• HE estimates clinical & economics outcomes of choices
• When making a decision, in addition to clinical benefits and
safety, economic aspects are considered
– Is it worth it ? (Health economics: HE)
– Is it affordable (Budget impact analysis)
• The focus today will be on “Health economics”
6
7. Total cost of arm new treatment
7
Health Economics
Choice
Costs of therapy
New Treatment
Costs of therapy
Usual care
Outcomes (new Tx)
& associated costs
Outcomes (current Tx)
& associated costs
Total cost of arm usual care
8. What is Economic Evaluation?
• A tool to demonstrate its value in terms of clinical
and economics consequences of decisions made
at the population level
• It answers the question: Whether the additional
benefits incurred from a technology is worth the
additional expenses incurred when comparing it to
the existing medical strategy?
9. Assessing both cost and outcome?
No Yes
Outcome only Cost only
No Outcome
description
Cost
description
Cost outcome
description
yes Efficacy,
effectiveness
Cost analysis Full
economic
evaluation
Compare at least 2 choices?
10. Value for Money
Outcomes Costs
• Benefits
• Safety
• Direct
• Indirect
10
11. Key Features
• Comparing clinical and economics consequences
• At least 2 choices are compared
• Need to define perspective (Target audience)
– Societal perspective
– Hospital perspective
– Payer perspective
– Patient perspective
12. Types of costs
• Costing
– Direct medical cost e.g. hospitalization, medical visit,
lab test, drug, procedures
– Direct non-medical cost e.g. transportation cost,
additional food incurred due to medical visits
– Indirect cost e.g. loss of productivity
13. Perspective Affects Costing
Direct medical
cost
Direct non-medical
cost
Indirect cost
Societal / / /
Hospital / - -
Payer / - -
Patient /
(out of pocket)
/ ??
14. Incremental
Cost-Effectiveness Ratio (ICER)
Total costs (new intervention) – Total costs (current standard)
Outcomes (new intervention) – Outcomes (current standard)
Examines balance between
additional health benefits VS
additional costs of achieving those health benefits
14
15. Cost-effectiveness Plane
Difference in Costs
Worse health, cost increased Better health, cost increased
Most common
cost
Difference in Health
(benefits)
Health
Health
Slope = cost
Cost saving
e.g. polio immunization
Not Desirable
QQuueessttioionnaabblele Most Desirable
Worse health, cost saved Better health, cost saved
15
16. Cost-effectiveness Plane
Difference in Costs
Worse health, cost increased Better health, cost increased
Most common
Most common
Difference in Health
(benefits)
Cost saving
e.g. polio immunization
Not Desirable
QQuueessttioionnaabblele Most Desirable
Simple Decision: Cost-savings
Worse health, cost saved Better health, cost saved
16
17. Slope =
cost
cost
Health
Difference in Health
(benefits)
Cost-effectiveness Plane
Difference in Costs
Worse health, cost increased
Health
Cost saving
e.g. polio immunization
Not Desirable
QQuueessttioionnaabblele Most Desirable
Worse health, cost saved Better health, cost saved
17
18. What is Health?
• Health can be a number of things
– Cost-effectiveness analysis (CEA)
• Difference in outcome e.g. 1 mmHg reduction,
1 fracture prevented
– Cost-utility analysis (CUA)
Health
cost
• The most commonly used in Thailand is QALY (Quality-adjusted life years)
• A unit of full quality years, calculated by the multiplication of “Number of
years” and “Quality of life during those years”
– E.g. Mr. A has DM nephropathy for 7 years, HRqol is 0.5, QALY is calcualted 7*0.5 = 3.5 QALY
18
19. Interpretation
• Meaning of ICER
– On average, the additional cost incurred to extend life for 1 year of
full quality.
• ICER = 30,000 RM/ QALY
– On average, the additional cost incurred to extend life for 1 year of
full quality is 30,000 RM
19
20. Criteria for “Being cost-effective”
• WHO recommendation: Use GDP/capita as criteria
(Threshold approach)
– <1 GDP = very cost-effective
– 1-3 GDP = maybe cost-effective
– > 3 GDP = not cost-effective
• Many countries do not state the threshold explicitly but
the value comes after analysis of decision with empirical
evidence
– USA: US $50,000 ~ US $100,000/QALY
– Australia: US $28,200 ~ US $51,000/LYG (1.26 ~ 2.29 GDP)
– NICE: £20,000–30,000/QALY (1.4~2.1 GDP/capita/QALY)
– GDP per capita of Malaysia 2012: USD 10,304 (IMF 2012)
< USD 10,304 30,000 RM Very cost-effective
< USD 30,912 (3 x 10,304) 30-90,000 RM Maybe cost-effective
> USD 30,912 (3 x 10,304) >90,000 RM Not cost-effective
20
21. • The ICER is less than $3,861 (120,000 THB) per QALY gained in 2012
21
• Adding IVIG to standard treatment in the treatment of childhood
idiopathic thrombocytopenia purpura with life-threatening bleeding is
possibly a cost-effective intervention in Thailand
27. Examples of application of HE for National List of Essential Medicine
Decision Making in Thailand (160,000 Baht/QALY, new decision rule 2014)
Health Interventions ICER(Baht/QALY) Coverage
Pegylate interferon alpha 2a and 2b + ribavirin for treatment chronic hepatitis C subtype 1 4 5 & 6 cost-saving Yes
Lamivudine or tenofovir for treatment of chronic hepatitis B cost-saving Yes
IVIG for steroid-resistant dermatomyositis cost-saving Yes
IVIG for steroid-resistant chronic inflammatory dymeliating polyneuropathy 57,290 Yes
Simvastatin for primary prevention of cardiovascular disease 82,000 Yes
Nilotinib for the second-line treatment of chronic myeloid leukemia 86,000 Yes
IVIG for life-threatening bleeding in pediatrics with idiopathic thrombocytopenia purpura 87,562 Yes
Oxaliplatin (FOLFOX) for treatment of advance colorectal cancer 126,000 Yes
Galantamine for treatment of mild-to-moderate Alzheimer's disease 157,000 No
Donepezil, rivastigmine for treatment of mild-to-moderate Alzheimer's disease 180,000-240,000 No
HPV vaccine at age 15 vs. Pap smear, 35-60 years old, q 5 years 247,000 No
Peritoneal dialysis vs. palliative care 435,000 Yes
Hemodialysis vs. palliative care 449,000 Yes
Osteoporosis drugs (alendronate, residronate, raloxifene) for primary and secondary prevention of
300,000-800,000 No
osteoporotic fractures
HPV vaccine at age > 25 vs. Pap smear, 35-60 years old, q 5 years 2,500,000 No
Transtuzumab in breast cancer 5,051,000 No
Imiglucerase for treatment of Gaucher disease type 1 6,300,000 Yes
Erythropoietin treatment in chemotherapyinduced anemia negative dominant No
Adefovir, entecavir, telbivudine, pegylate interferon alpha 2a for treatment of chronic hepatitis B negative dominant No
23 27